Indian Pharma Major Glenmark Announces Hocine Sidi-Said’s Exit From Board
Advertisement
Advertisement
Drug maker
Hocine has now joined Pharma International, a one of the leading generic pharmaceutical firm in Jordan, as the chief executive officer since November 2014. The company is backed by private equity and has a special focus on emerging markets.
Hocine had also founded advisory and investment firm called Bio-nAbler in 2009. Previously, he has served other pharmaceutical majors such as Moksha8 and Pfizer and has nearly 25 years of experience across emerging markets.
Hocine had joined Glenmark’s Board in December 2009.
Advertisement
Advertisement
- Love in the time of elections: Do politics spice up or spoil dating in India?
- Samsung Galaxy S24 Plus review – the best smartphone in the S24 lineup
- Household savings dip over Rs 9 lakh cr in 3 years to Rs 14.16 lakh cr in 2022-23
- Misleading ads: SC says public figures must act with responsibility while endorsing products
- Here’s what falling inside a black hole would look like, according to a NASA supercomputer simulation
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market